(MedPage Today) — Scoring tools validated to identify people at high risk of having transthyretin amyloid cardiomyopathy (ATTR-CM) still leave room for improvement in diverse populations.
The ATTR-CM score and the T-Amylo score have been validated…
Source link : https://www.medpagetoday.com/spotlight/attr-cm/117268
Author :
Publish date : 2025-09-02 18:34:00
Copyright for syndicated content belongs to the linked Source.
